Glycan-based scaffolds and nanoparticles as drug delivery system in cancer therapy
- PMID: 38799466
- PMCID: PMC11116596
- DOI: 10.3389/fimmu.2024.1395187
Glycan-based scaffolds and nanoparticles as drug delivery system in cancer therapy
Abstract
Glycan-based scaffolds are unique in their high specificity, versatility, low immunogenicity, and ability to mimic natural carbohydrates, making them attractive candidates for use in cancer treatment. These scaffolds are made up of glycans, which are biopolymers with well biocompatibility in the human body that can be used for drug delivery. The versatility of glycan-based scaffolds allows for the modulation of drug activity and targeted delivery to specific cells or tissues, which increases the potency of drugs and reduces side effects. Despite their promise, there are still technical challenges in the design and production of glycan-based scaffolds, as well as limitations in their therapeutic efficacy and specificity.
Keywords: cancer; drug; glycan; glycosylation; scaffolds.
Copyright © 2024 Qin, Teng, Dai, Wang and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Figueiredo T, Jing J, Jeacomine I, Olsson J, Gerfaud T, Boiteau JG, et al. Injectable self-healing hydrogels based on boronate ester formation between hyaluronic acid partners modified with benzoxaborin derivatives and saccharides. Biomacromolecules. (2020) 21:230–9. doi: 10.1021/acs.biomac.9b01128 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
